Children's Hospital of Chongqing Medical University
Phase
Observational
Started
2018-10-01
Last updated
2020-07-20
Condition(s) studied
Liver DiseasesLiver Transplant; ComplicationsPediatric ALL
Investigational drug(s) / intervention(s)
No intervention
No intervention: There are no interventions because it is a protocol study
Study summary
The purpose of the pediatric liver transplant biobank is to systematically collect clinical specimens from pediatric end-stage liver disease. It is expected to contribute to the research and development of paediatric end-stage liver disease in the future.
Eligibility
Sex
ALL
Min age
1 Month
Max age
18 Years
Healthy volunteers
Accepted
Inclusion Criteria:
1. Children diagnosed with end-stage liver disease.
2. Liver transplantation in our hospital.
3. informed patient consent.
4. long-term follow-up in our hospital.
Exclusion Criteria:
No fixed contact information, difficult to follow up the patients.
Primary outcome measure(s)
Biological sample bank — 2 years A repository of biological samples from patients who will join the project, will be organised at the biobank center of the Children's Hospital of Chongqing Medical University(CHCMU) under the responsibility of the experienced staff at the Department of Hepatic.
Integrated health data platform — 2 years Collect patient clinical test information and establish diagnostic database.
Trial sites (1)
Facility
City
Region
Status
Children's Hospital of Chongqing Medical University
Chongqing
Chongqing Municipality
Recruiting
More Children's Hospital of Chongqing Medical University trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.